5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-2-(trifluoromethyl)pyrimidine, 95.0%, 500mg

tri-sodio citrato diidrato, 500 g

4-CHLORO-3-(METHYLTHIO)BENZOIC ACID, 95.0%, 250mg

8-methyl-4-(pyridine-3-carbonyl)-1-oxa-4-azaspiro[4.5]decane-3-carboxylic acid, 95.0%, 1g

4-amino-3-(2-methylphenyl)-4,5-dihydro-1H-1,2,4-triazole-5-thione, 97%, 250mg

2-Methyl-10H-benzo[b]thieno[2,3-e][1,4]diazepin-4-amine hydrochloride, 95.0%, 25g

4-(1,1,2,2-Tetrafluoroethoxy)aniline, 98.0%, 1g

QUILLAIC ACID, 95%, 50mg

(6-Chloropyridin-2-yl)methanamine, 95%, 100mg

Colonne di protezione HPLC (analitiche) NUCLEODUR® C8 Gravity 3 µm, 4x3 mm, 3 Pezzo(i)

Tert-butyl(3r,5r)-3-amino-5-hydroxypiperidine-1-carboxylate, 97%, 250mg

5-Oxo-thiomorpholine-3-carboxylic acid, 1g

3-(2-Cyanopropan-2-yl)-N-(3-((7-methoxyquinazolin-4-yl)amino)-4-methylphenyl)benzamide, 97.0%, 50mg